In their analysis, the transcriptional activation of GAS6-AS2 lncRNA led to the overactivation of the GAS6/TAM pathway, which is the drug resistance mechanism of many cancers, including AML (Bester et al., 2018). This evidence concerns the gene GAS6 and acute myeloid leukemia.